These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2949548

  • 21. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A, Hecquet F, Guilmard C, Soulard C, Braquet P.
    Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
    [Abstract] [Full Text] [Related]

  • 22. Platelet-activating factor in organ transplant rejection.
    Foegh ML, Chambers E, Khirabadi BS, Nakanishi T, Ramwell PW.
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():377-82. PubMed ID: 2526501
    [No Abstract] [Full Text] [Related]

  • 23. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.
    Cirino M, Lagente V, Lefort J, Vargaftig BB.
    Prostaglandins; 1986 Jul; 32(1):121-6. PubMed ID: 3763941
    [Abstract] [Full Text] [Related]

  • 24. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
    Sanchez Crespo M, Inarrea P, Nieto ML, Fernandez-Gallardo S.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
    [Abstract] [Full Text] [Related]

  • 25. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
    Lagente V, Touvay C, Randon J, Desquand S, Cirino M, Vilain B, Lefort J, Braquet P, Vargaftig BB.
    Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
    [Abstract] [Full Text] [Related]

  • 26. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
    Adnot S, Joseph D, Vargaftig BB.
    Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
    [Abstract] [Full Text] [Related]

  • 27. Comparison of three paf-acether receptor antagonist ginkgolides.
    Korth R, Nunez D, Bidault J, Benveniste J.
    Eur J Pharmacol; 1988 Jul 26; 152(1-2):101-10. PubMed ID: 2850196
    [Abstract] [Full Text] [Related]

  • 28. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P.
    Prostaglandins; 1987 Sep 26; 34(3):337-49. PubMed ID: 3432553
    [Abstract] [Full Text] [Related]

  • 29. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F, Omini C, Rossoni G, Braquet P.
    Pharmacol Res Commun; 1986 Sep 26; 18(9):775-93. PubMed ID: 3099317
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H, Plantavid M, Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Biochem Biophys Res Commun; 1985 Oct 30; 132(2):460-6. PubMed ID: 2998370
    [Abstract] [Full Text] [Related]

  • 31. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether.
    Bureau M, Joseph D, Vargaftig BB.
    Prostaglandins; 1987 Jan 30; 33(1):37-50. PubMed ID: 3035615
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
    Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB.
    Pharmacol Res Commun; 1986 Aug 30; 18 Suppl():119-26. PubMed ID: 3774840
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
    Harczy M, Maclouf J, Pradelles P, Braquet P, Borgeat P, Sirois P.
    Pharmacol Res Commun; 1986 Aug 30; 18 Suppl():111-7. PubMed ID: 3095849
    [Abstract] [Full Text] [Related]

  • 34. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.
    Pignol B, Hénane S, Mencia-Huerta JM, Rola-Pleszczynski M, Braquet P.
    Prostaglandins; 1987 Jun 30; 33(6):931-9. PubMed ID: 3313526
    [Abstract] [Full Text] [Related]

  • 35. [Renal diseases and platelet activating factor].
    Pirotzky E, Colliez P, Guilmard C, Braquet P.
    Pediatrie; 1989 Jun 30; 44(3):163-7. PubMed ID: 2740184
    [Abstract] [Full Text] [Related]

  • 36. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
    Smith PF, Maclennan K, Darlington CL.
    J Ethnopharmacol; 1996 Mar 30; 50(3):131-9. PubMed ID: 8691847
    [Abstract] [Full Text] [Related]

  • 37. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.
    Adnot S, Lefort J, Braquet P, Vargaftig BB.
    Prostaglandins; 1986 Dec 30; 32(6):791-802. PubMed ID: 3562865
    [Abstract] [Full Text] [Related]

  • 38. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.
    Adnot S, Lefort J, Lagente V, Braquet P, Vargaftig BB.
    Pharmacol Res Commun; 1986 Aug 30; 18 Suppl():197-200. PubMed ID: 3774845
    [No Abstract] [Full Text] [Related]

  • 39. Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist.
    Braquet P, Bourgain RH.
    Adv Exp Med Biol; 1987 Aug 30; 215():215-35. PubMed ID: 3314403
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
    Rola-Pleszczynski M, Pignol B, Pouliot C, Braquet P.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):754-60. PubMed ID: 3493773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.